Aprepitants plasmakoncentrationer, opnået efter 3- dages behandlingsregime med peroral aprepitant, forventes at beslaglægge mere end 95% af hjernens NK1- receptorer.
Aprepitant plasma concentrations achieved with the 3-day regimen of oral aprepitant are predicted to provide greater than 95% occupancy of brain NK1 receptors.